Advanced 3D cell models for cancer biology using real time live-cell analysis

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Principal R&D Scientist, Essen BioScience
    Biography
      Kalpana is currently a Principal Scientists within our UK Biology R&D team based at Essen BioSciences European laboratories. A highly experienced industrial pharmacologist with over 20 years of experience gained from pharmaceutical (GlaxoSmithKline) and contract research (BioFocus and Argenta) laboratories. A track record in applied drug discovery, latterly leading and influencing discovery programme teams. Trained initially as an in vitro pharmacologist, Kalpana went on to focus in the field of G-protein coupled receptor drug discovery and specialise in designing and developing plate-based cellular assays to support automated High Throughput Screening and Compound Profiling activities as well as generating mechanism of action follow-up assays. Kalpana joined Essen in 2011, applying her extensive expertise to leading R&D projects developing cellular assays for quantitative live cell analysis.

    Abstract:

    Integrated protocols and live-cell analysis solutions for different 3D tumor models

    In the search for greater clinical translation, cancer researchers are increasingly turning to more complex live-cell assay systems that recapitulate key aspects of the tumor microenvironment. These include (1) more relevant tissue organization, (2) bio-matrices containing structural proteins and growth factors, and (3) the presence of stromal and immune cells. In this webinar, we describe integrated protocols and live-cell analysis solutions for different 3D tumor models, ranging from simple mono-culture single spheroid assays through to multi-spheroid tumor/fibroblast and tumor/immune cell co-cultures in a Matrigel biomatrix.

    You will learn how to:

    • Assemble 96-well 3D spheroid assays in both round-bottom ultra-low attachment microplates, and flat plates on a Matrigel base
    • Automatically acquire and analyse images over time, using the new IncuCyte S3 DF Brightfield modality and Spheroid module
    • Quantify tumor growth, morphology and viability, either label-free or with fluorescent cell health markers
    • Study the impact of stromal cells and immune cells on tumor biology in these 3D systems
    • Gain greater biological insight and productivity in your 3D tumor assays

    Show Resources
    You May Also Like
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    NOV 18, 2019 07:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    Loading Comments...
    Show Resources